Quest Diagnostics Incorporated (DGX): Price and Financial Metrics


Quest Diagnostics Incorporated (DGX): $136.36

-1.94 (-1.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DGX POWR Grades


  • DGX scores best on the Quality dimension, with a Quality rank ahead of 94.28% of US stocks.
  • The strongest trend for DGX is in Momentum, which has been heading down over the past 163 days.
  • DGX ranks lowest in Momentum; there it ranks in the 16th percentile.

DGX Stock Summary

  • With a market capitalization of $16,827,298,338, Quest Diagnostics Inc has a greater market value than 86.33% of US stocks.
  • DGX's current price/earnings ratio is 7.7, which is higher than just 15.69% of US stocks with positive earnings.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for DGX comes in at 17.04% -- higher than that of 88.55% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Quest Diagnostics Inc are DAR, PKG, AMCR, FOXA, and TREX.
  • DGX's SEC filings can be seen here. And to visit Quest Diagnostics Inc's official web site, go to www.questdiagnostics.com.

DGX Valuation Summary

  • In comparison to the median Healthcare stock, DGX's EV/EBIT ratio is 75.09% lower, now standing at 7.3.
  • Over the past 243 months, DGX's price/sales ratio has gone down 0.
  • Over the past 243 months, DGX's price/sales ratio has gone down 0.

Below are key valuation metrics over time for DGX.

Stock Date P/S P/B P/E EV/EBIT
DGX 2021-08-31 1.7 3.2 8.3 7.3
DGX 2021-08-30 1.7 3.1 8.2 7.3
DGX 2021-08-27 1.6 3.1 8.1 7.2
DGX 2021-08-26 1.7 3.1 8.1 7.2
DGX 2021-08-25 1.7 3.1 8.1 7.2
DGX 2021-08-24 1.7 3.1 8.1 7.2

DGX Growth Metrics

    The 3 year revenue growth rate now stands at 0.28%.
  • Its 3 year net cashflow from operations growth rate is now at 43.73%.
  • Its year over year revenue growth rate is now at 34.97%.
DGX's revenue has moved up $3,412,000,000 over the prior 49 months.

The table below shows DGX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 11,046 2,293 2,184
2021-06-30 11,058 2,594 2,247
2021-03-31 10,335 2,489 1,801
2020-12-31 9,437 2,005 1,431
2020-09-30 8,361 1,812 1,105
2020-06-30 7,531 1,249 752

DGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DGX has a Quality Grade of B, ranking ahead of 93.32% of graded US stocks.
  • DGX's asset turnover comes in at 0.812 -- ranking 31st of 81 Healthcare stocks.
  • SSY, LH, and BIOC are the stocks whose asset turnover ratios are most correlated with DGX.

The table below shows DGX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.812 0.403 0.404
2021-06-30 0.805 0.412 0.417
2021-03-31 0.750 0.404 0.340
2020-12-31 0.709 0.385 0.277
2020-09-30 0.643 0.362 0.221
2020-06-30 0.604 0.334 0.162

DGX Price Target

For more insight on analysts targets of DGX, see our DGX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $157.67 Average Broker Recommendation 1.56 (Moderate Buy)

DGX Stock Price Chart Interactive Chart >

Price chart for DGX

DGX Price/Volume Stats

Current price $136.36 52-week high $174.16
Prev. close $138.30 52-week low $113.36
Day low $134.09 Volume 360,063
Day high $138.34 Avg. volume 1,243,134
50-day MA $155.93 Dividend yield 1.79%
200-day MA $144.13 Market Cap 16.73B

Quest Diagnostics Incorporated (DGX) Company Bio


Quest Diagnostics provides diagnostic testing information services in the United States and internationally. The company offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices, analytic, on-site prevention, and wellness services, and risk assessment services for the life insurance industry. The company was founded in 1967 and is founded in Madison, New Jersey.


DGX Latest News Stream


Event/Time News Detail
Loading, please wait...

DGX Latest Social Stream


Loading social stream, please wait...

View Full DGX Social Stream

Latest DGX News From Around the Web

Below are the latest news stories about Quest Diagnostics Inc that investors may wish to consider to help them evaluate DGX as an investment opportunity.

Down 17.9% in 4 Weeks, Here's Why Quest Diagnostics (DGX) Looks Ripe for a Turnaround

Quest Diagnostics (DGX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Yahoo | January 21, 2022

Bridge to Health Connects New Mexico Residents to Local Resources to Help Families Live Healthier Lives

Over 2,200 attend events in Las Cruces and Albuquerque; over 1,100 bags of groceries distributed to families

Yahoo | January 20, 2022

Quest Diagnostics (DGX) Expands Extended Care With New Buyout

This latest acquisition builds on Quest Diagnostics' (DGX) 2018 acquisition of Mobile Medical Examination Service (MedXM), a provider of home-based health risk assessments and related services.

Yahoo | January 19, 2022

Quest Diagnostics Launches Virtual Preventive Care Service Through QuestDirect™ to Help Individuals Take Control of Their Health

Adults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the consumer-initiated testing platform from Quest Diagnostics (NYSE: DGX). This new offering evaluates more than 100 health-related data points -- combining access to the same laboratory tests doctors order, a behavioral health risk assessment and biometric measurements, such as weight and blood pressure, to give individ

Yahoo | January 19, 2022

Quest diagnostics acquires Pack Health to improve value-based care in stock and cash deal

Quest Diagnostics (DGX) is acquiring Pack Health in an all-cash equity transaction.Pack Health is a patient-engagement company that helps individuals adopt healthier behaviors to

Seeking Alpha | January 18, 2022

Read More 'DGX' Stories Here

DGX Price Returns

1-mo N/A
3-mo -4.85%
6-mo -2.61%
1-year 11.11%
3-year 69.69%
5-year 62.17%
YTD -20.84%
2021 47.86%
2020 14.11%
2019 31.13%
2018 -13.84%
2017 9.16%

DGX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DGX Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9291 seconds.